BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
326.06
-2.65 (-0.81%)
At close: Sep 26, 2025, 4:00 PM EDT
321.00
-5.06 (-1.55%)
After-hours: Sep 26, 2025, 7:42 PM EDT

BeOne Medicines AG Stock Forecast

Stock Price Forecast

The 10 analysts that cover BeOne Medicines AG stock have a consensus rating of "Strong Buy" and an average price target of $340.7, which forecasts a 4.49% increase in the stock price over the next year. The lowest target is $311 and the highest is $385.

Price Target: $340.7 (+4.49%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$311$340.7$345$385
Change-4.62%+4.49%+5.81%+18.08%

Analyst Ratings

The average analyst rating for BeOne Medicines AG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingApr '25May '25Jun '25Jul '25Aug '25Sep '25
Strong Buy222222
Buy557778
Hold000000
Sell000000
Strong Sell000000
Total7799910

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Barclays
Barclays
Buy
Initiates
$385
BuyInitiates$385+18.08%Sep 18, 2025
RBC Capital
RBC Capital
Buy
Maintains
$349$364
BuyMaintains$349$364+11.64%Aug 7, 2025
Guggenheim
Guggenheim
Strong Buy
Maintains
$350$365
Strong BuyMaintains$350$365+11.94%Aug 7, 2025
JP Morgan
JP Morgan
Buy
Maintains
$321$345
BuyMaintains$321$345+5.81%Jul 17, 2025
RBC Capital
RBC Capital
Buy
Maintains
$311$349
BuyMaintains$311$349+7.04%Jul 16, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
37.98B
from 3.81B
Increased by 896.81%
Revenue Next Year
37.17B
from 37.98B
Decreased by -2.13%
EPS This Year
0.78
from -6.12
EPS Next Year
0.70
from 0.78
Decreased by -9.94%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2025
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2025
Revenue
308.87M1.18B1.42B2.46B3.81B37.98B37.17B
Revenue Growth
-27.87%280.83%20.37%73.65%54.97%896.81%-2.13%
EPS
-19.47-15.71-19.43-8.45-6.120.780.70
EPS Growth
-------9.94%
Forward PE
-----417.40463.49
No. Analysts
-----89
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High40.0B48.9B
Avg37.2B45.0B
Low35.1B41.4B

Revenue Growth

Revenue Growth20252026202720282029
High
949.0%
31.6%
Avg
875.6%
21.0%
Low
822.3%
11.3%

EPS Forecast

EPS20252026202720282029
High1.563.94
Avg0.702.68
Low0.211.50

EPS Growth

EPS Growth20252026202720282029
High-
459.7%
Avg-
281.5%
Low-
113.1%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.